V.A.C.® Therapy System in operating room on patient leg

3M Wound Care Solutions

Transforming wound care through science

Your goal is to protect and support your patient along their surgical journey, hospital stay or community care. We are here to help address your challenges with leading innovations in negative pressure wound therapy (NPWT), surgical incision management, infection prevention, advanced wound care and skin integrity to help meet the needs of the people you care for every day.

We can help drive toward better outcomes for your patients, focusing on data-rich evidence, world-class education, and innovative products. When we combine 3M’s science with your care and expertise, amazing things happen.


Wound care is evolving. Together, we can help guide its future.

No matter your patients’ needs, we are with you and your teams every step of the way. We provide you with innovative products that are rooted in clinical evidence, that help promote wound healing and drive effective outcomes.

  • Help your patients return to their lives after surgery by optimising post-operative healing. 3M’s innovative incision and wound management solutions can help in reducing the risk of complications including surgical site infections (SSI)¹⁻⁹. Reducing the length of hospital stay can help lower total cost of care¹⁰. From hospital to home, 3M innovations help solve wound healing challenges like no other, to help patients heal and get back on the road to recovery. 3M is with you every step of the way.

  • Every wound is unique and may require a cascading approach to treatment.

    From negative pressure wound therapy to a full line of advanced wound dressings and skin integrity, see how we can help your patients throughout their journey to healing.

     

  • Skin damage presents negative clinical outcomes resulting in potential complications such as infection, pain and suffering, and a poor patient experience.

    In addition, skin damage increases the time and cost of care. Exposure over time to factors such as irritants, moisture, friction, shear and adhesives can lead to one or more types of Moisture Associated Skin Damage (MASD)


Keep up with the latest 3M news, events and information

Keep up with the latest 3M news, events and information

SIGN UP

Education and training from experts in wound management

  • Deepen your expertise through professional training opportunities and educational resources designed just for you. Learn from experts in a wide range of fields in the healthcare industry.

  • Explore cutting-edge, evidence-based medical education on advanced surgical techniques management.


Helping to improve outcomes though innovation and the brands you rely on.

  • For 25 years, 3M™ V.A.C.® Therapy has been shown to be a successful way to manage wounds and support healing. Explore how 3M delivers the innovative negative pressure wound therapy technology and evidence-based outcomes you need with the safety and confidence your patients can trust.

    3M™ V.A.C.® Therapy

  • More than 90 percent of chronic wounds contain bacteria and fungi bioburden. 3M™ Veraflo™ Therapy allows you to cleanse the wound and promote granulation tissue formation at the same time.

    Start smart and see why Veraflo Therapy should be your first choice in managing complex wounds.

  • Simplify your skin integrity needs with 3M™ Cavilon™ Skin Care Solutions.

    With innovative solutions including a unique advanced skin protectant, barriers films, creams and wipes. Find optimal solutions to manage and protect at-risk skin.

     

  • Compression therapy is considered the gold standard of care for managing lower extremity oedema and venous ulceration . 3M™ Coban™ 2 Compression System provides a comfortable, rigid sleeve that consistently delivers the right amount of compression to reduce oedema.

  • Prevena Therapy is uniquely designed to manage and protect the surgical incision in patients at risk of surgical site complications, including infection⁸. Prevena Therapy has been proven to help reduce surgical site complications and improve patient outcomes across multiple surgical specialties¹⁻⁹,¹¹. Helping to reduce the burden on healthcare facilities through reduced reoperations²,⁵,⁸ and associated additional costs of treatment⁹,¹⁰.

  • Clinician applying Coban 2 and 3m Kerramax Care Super Absorbent Dressing
    3M™ Kerramax Care™ Super-Absorbent Dressings

    Highly exuding wounds are demanding for both clinician and patient. 3M™ Kerramax Care™ Super-Absorbent Dressings with advanced Exu-Safe™ Technology, unique lateral wicking system and ability to sequester bacteria¹²,¹³ and MMPs,¹⁴ are ready to meet these demands helping to transform patient outcomes.


Call to action banner blue

Have a question? We are here to help.

Contact Us

References

    1. Ferrando PM, Ala A, Bussone R, Bergamasco L, Actis Perinetti F, Malan F. Closed incision negative pressure therapy in oncological breast surgery: comparison with standard care dressings. Plast Reconstr Surg Glob Open. 2018 Jun 15;6(6):e1732. doi:10.1097/GOX000000000000173
    2. Pleger SP, Nink N, Elzien M, Kunold A, Koshty A, Boning A. Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study. Int Wound J. 2018;15(1):75-83.
    3. Cooper HJ, Bas MA. Closed-incision negative-pressure therapy versus antimicrobial dressings after revision hip and knee surgery: a comparative study. J Arthroplasty. 2016 May;31(5):1047-1052. doi:10.1016/j.arth.2015.11.010
    4. Redfern RE, Cameron-Ruetz C, O’Drobinak SK, Chen JT, Beer KJ. Closed incision negative pressure therapy effects on postoperative infection and surgical site complication after total hip and knee arthroplasty. J Arthroplasty. 2017;32:3333-3339. doi:10.1016/j.arth.2017.06.019
    5. Newman JM, Siqueira MBP, Klika AK, Molloy RM, Barsoum WK, Higuera CA. Use of closed incisional negative pressure wound therapy after revision total hip and knee arthroplasty in patients at high risk for infection: a prospective, randomized clinical trial. J Arthroplasty. 2019 Mar;34(3):554-559e1. doi:10.1016/j.arth.2018
    6. Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
    7. Grauhan O, Navasardyan A, Hofmann M, et al. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
    8. Gabriel A, Sigalove S, Sigalove N, et al. The impact of closed incision negative pressure therapy on postoperative breast reconstruction outcomes. Plast Reconstr Surg Glob Open. 2018 Aug; 6(8): e1880.doi:10.1097/GOX.0000000000001880
    9. Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, Salvatore D, Reiter D, DiMuzio P. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018 Dec;68(6):1744-1752. doi: 10.1016/j.jvs.2018.05.224. Epub 2018 Aug 17. PMID: 30126781.
    10. Anderson, D., et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology. 2014; 5(6), 605-627. doi:1. Retrieved from http://www.jstor.org/stable/10.1086/676022 doi:1
    11. Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
    12. Cooper, R. An investigation into the ability of Kerramax Care™ and Kerrafoam™ to bind bacteria. Cardiff Metropolitan University. September 2013.
    13. Thomas, H & Westgate, S.J. An in vitro comparison of MRSA and P. aeruginosa sequestration by five super-absorbent wound dressings. Poster presented at EWMA; 11–13 May 2016; Bremen, Germany.
    14. Dr. Cochrane, C.A. Evaluation of matrix metalloproteinases by wound care products. University of Liverpool, UK. July 2011.